Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert M Wilechansky, M.D.

Concepts (68)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fellowships and Scholarships2202310661.020 Why?
Toxocariasis12019110.700 Why?
Enteritis120191600.630 Why?
Clinical Competence2202346810.620 Why?
Gastritis120191910.600 Why?
Duodenostomy1201670.600 Why?
Pancreatic Pseudocyst120161100.570 Why?
Eosinophilic Esophagitis120191630.570 Why?
Pancreatic Ducts120163280.500 Why?
Eosinophilia120195310.500 Why?
Cholangiopancreatography, Endoscopic Retrograde120165040.470 Why?
Liver Diseases1202212520.450 Why?
Drainage1201611400.390 Why?
Colitis1201911490.380 Why?
Fatty Liver220247280.310 Why?
Renal Insufficiency, Chronic1201921950.250 Why?
Hepatorenal Syndrome12023610.220 Why?
Cholangitis, Sclerosing120221590.190 Why?
Cholestasis120223780.170 Why?
Liver Cirrhosis6202418640.160 Why?
Natural Language Processing1202410350.140 Why?
Dairy Products120194980.130 Why?
Albuminuria120196830.130 Why?
Anti-Inflammatory Agents1202417880.120 Why?
Aspirin1202432780.100 Why?
Acute Kidney Injury1202319670.090 Why?
Liver2202474700.090 Why?
Feeding Behavior1202231870.090 Why?
Massachusetts1201986620.070 Why?
Incidence22023209280.060 Why?
Longitudinal Studies12019139210.060 Why?
Prevalence12019151940.050 Why?
Humans1220247420880.050 Why?
Aged420241629440.050 Why?
End Stage Liver Disease120243140.040 Why?
Diabetes Mellitus, Type 212023116950.040 Why?
Middle Aged420242131270.040 Why?
Alkaline Phosphatase120228650.040 Why?
Necrosis1202316430.040 Why?
Pancreatic Neoplasms1201652490.040 Why?
Glucagon-Like Peptide 1120193340.040 Why?
Obesity12019127050.040 Why?
Male520243495380.040 Why?
Potassium Channels, Voltage-Gated120161410.030 Why?
Female520243795920.030 Why?
Vitamin E120198690.030 Why?
Diet2202379230.030 Why?
Treatment Outcome12019629660.030 Why?
RNA1202227470.030 Why?
Biopsy1202467560.030 Why?
Inflammation22023105780.030 Why?
Carcinoma, Hepatocellular1202422110.030 Why?
Double-Blind Method12024120170.020 Why?
Bariatric Surgery120199400.020 Why?
Body Weight1201946640.020 Why?
Liver Neoplasms1202442490.020 Why?
Weight Loss1201926040.020 Why?
Insulin Resistance1201938610.020 Why?
Retrospective Studies22023770980.020 Why?
Algorithms12024138530.010 Why?
Exercise1201956110.010 Why?
Cross-Sectional Studies12023249130.010 Why?
Follow-Up Studies12024390040.010 Why?
Prospective Studies12023531870.010 Why?
Young Adult12024563500.010 Why?
Prostatic Neoplasms12019110390.010 Why?
Adolescent12024856490.010 Why?
Adult120242137120.010 Why?
Wilechansky's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.